4
Changes in Ownership
FENNEC PHARMACEUTICALS INC. Filed Acc 0001104659-21-151821
Options or other derivatives
- Chief Executive Officer acquired 300,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Raykov Rosty · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-12-20 | Grant or award : show line 1 in the form Stock Option (right to buy) | +300,000 | $4.08 | 2031-12-20 | 300,000 | 300,000 | D |
Loading xslF345X03/tm2135965-1_4seq1.xml…